Jiangsu Alpha Pharmaceutical Co., Ltd.

Products

1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate

    • Product Name: 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate
    • Chemical Name (IUPAC): 2-[[(4-carbamimidoylphenyl)methylamino]-1-methyl-5-(carboxycarbonyl)benzimidazol-2-yl]-N-(pyridin-2-yl)-N-(2-ethoxy-2-oxoethyl)acetamide 4-methylbenzenesulfonate
    • CAS No.: 112809-51-5
    • Chemical Formula: C27H29N7O4•C7H8O3S
    • Form/Physical State: Solid
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@bouling-chem.com
    • Manufacturer: Jiangsu Alpha Pharmaceutical Co., Ltd.
    • CONTACT NOW
    VTB
    Specifications
    HS Code 995764
    Chemical Name 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate
    Molecular Formula C32H35N7O5S
    Molecular Weight 629.73 g/mol
    Appearance White to off-white powder
    Solubility Soluble in DMSO, slightly soluble in water
    Storage Temperature 2-8°C (refrigerated)
    Purity ≥98% (HPLC)
    Synonyms Dabigatran etexilate p-toluenesulfonate
    Usage Used as an anticoagulant; research chemical
    Pka Approximately 4.0 (carboxylic acid moiety)
    Melting Point About 156-158°C (dec.)
    Hazard Classification Irritant; may cause skin and eye irritation

    As an accredited 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The chemical is packaged in a 5g amber glass bottle with a tamper-evident seal and detailed labeling for laboratory use.
    Container Loading (20′ FCL) Container Loading (20′ FCL): Securely packed 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate, using appropriate drums and pallets for safe sea transport.
    Shipping This chemical, `1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate`, should be shipped in tightly sealed containers, protected from light and moisture. Use cold packs and secondary containment if required. Follow all relevant chemical transport regulations and include appropriate hazard labeling and documentation during shipping.
    Storage Store **1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate** in a tightly sealed container, protected from light and moisture, at 2–8°C (refrigerator). Keep away from incompatible substances such as strong oxidizers and acids. Use in a well-ventilated area while wearing appropriate personal protective equipment. Ensure storage area is clearly labeled and access is restricted to qualified personnel.
    Shelf Life Shelf life of 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylic acid para-toluene sulfonate is typically 2–3 years if stored properly.
    Application of 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate

    Applications of 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate in Industrial Manufacturing

    As a direct manufacturer specializing in high-purity intermediates, we supply 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate for key applications in biopharmaceutical production, clinical diagnostic reagent synthesis, advanced fine chemical manufacturing, and life science research products. Targeted process integration and precise formulation support efficient, compliant, and safe downstream operations.

    1. API Intermediate for Novel Anticoagulant Drug Synthesis

    Pharmaceutical partners employ this compound as a core intermediate during the multi-step synthesis of next-generation direct thrombin inhibitors. Downstream processes involve regioselective amidation and stepwise functional group assembly executed under cGMP conditions. Our material, manufactured according to advanced QC protocols, assures batch-to-batch reproducibility and minimizes impurity carryover, supporting both process validation and scale-up registration. Collaboration focuses on compliant impurity profiling, in-process control standards, and critical quality attribute management from kilo-lab through commercial production.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Building Block in Specialty Diagnostic Reagents

    Leading diagnostics companies utilize the compound as a structural component during synthesis of chromogenic peptide substrates for coagulation assays. Precision in trace-level impurity control ensures stable signal generation critical for quantitative clinical tests. Stringent release testing on every lot enables reliable downstream use in automated analyzer reagent kits, where lot uniformity and absence of interfering residues dictate final test reproducibility.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Intermediate for Functional Dye and Probe Synthesis

    Fine chemical manufacturers integrate this benzimidazole-based compound into synthetic lines for specialty dyes and fluorescent probes used in biomedical and imaging applications. The presence of amidinophenyl and pyridyl groups allows for selective functionalization, producing signal-modified dyes that attach to biomolecular analytes. Product QC includes high-resolution NMR, LC-MS, and HPLC analytics to verify chemical identity, signal stability, and photostability against manufacturing release criteria.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Precursor in Customized Research Biochemical Kits

    Research tool suppliers employ the compound as a regulated precursor in producing high-purity biochemical assay kits aimed at academic and industrial research. The molecular structure enables the development of modified enzyme inhibitors and substrate analogs for functional genomics and drug discovery workflows. On-site formulation, validated analytical release, and precise weight-in protocols underpin supply reliability for repetitive laboratory and pilot-scale customer applications.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@bouling-chem.com

    Inquiry

    Get Free Quote of Jiangsu Alpha Pharmaceutical Co., Ltd.

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate

    The Chemical from the Manufacturer’s Viewpoint

    Every chemical in our catalog gets its own story during research and manufacturing. Some take years to mature before production, others need only incremental tweaking to fit their role in biochemical applications. The synthesis and consistent quality of 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate, which we sometimes refer to in shorthand as BzA-PAPA-PTS, came out of specific collaboration with both synthetic chemists and end-users in pharmaceutical research and biochemical assays.

    Naming conventions in chemistry speak volumes about structure, but what matters most in regular production—batch in, batch out—is less about the name and more about reliability and real density of the active ingredient. With this compound, we saw an increase in targeted feedback from labs demanding less residual solvent, tighter melting point windows, and a solid-state with fewer crystal polymorphs. At the bench, these requests seem reasonable, but scaling to multi-kilogram runs transforms each parameter into a challenge.

    Manufacturing Insight

    Our choice to produce this compound as a para-toluene sulfonate salt stemmed from feedback straight from formulation chemists. Free base forms of molecules with guanidine or benzimidazole skeletons tend to display poor solubility and unpredictable stability in storage. With the para-toluene sulfonate salt, the powder forms readily, handles without visible hygroscopicity, and keeps its color well even after repeated opening and closing of storage containers. This matters for assay reproducibility. Each sub-batch of material undergoes wet chemistry identification for toluenesulfonate, confirming both purity and homogeneity.

    The model we settled on comes in white to off-white crystalline form, averaging a density of 1.5 g/cm3. Typical melting points sit in the 228–233°C range, with HPLC showing purity over 99%. For labs, reproducibility means not having to recalibrate reference spectra or solvents for every procurement event. Batched properly, this salt also avoids the trace oxidized aromatic impurities sometimes seen elsewhere, since our crystallization step uses a toluene-free work-up that limits environmental contamination.

    Applications: From Theory to Practice

    There’s a reason researchers turn to benzimidazole-derived guanidines. The combination of the amidine group and fused aromatic rings lends strong salt bridge forming capacity, which pharmacologists like in draft drug candidates. We see BzA-PAPA-PTS pulled from inventory mostly for use in anti-thrombotic or anti-inflammatory screening, sometimes ending up as a co-crystallization partner for X-ray crystallography.

    Lab teams working on protease inhibition mention its binding characteristics. Chemical teams gravitate toward its robust reactivity in coupling reactions, especially those relying on amide or carbamate linkages. To prepare it at larger scale, we chose to optimize the amidation step to minimize byproducts, using N,N'-diisopropylcarbodiimide as a coupling agent and running the benzimidazole ring closure under anhydrous conditions to keep side product formation under control.

    Where it gets more interesting is the way this compound behaves under real stress. Unlike many related guanidines, the presence of both a pyridyl substituent and an ethoxycarbonylethyl moiety tempers its charge characteristics, boosting both lipophilicity and membrane crossing in biological tests. Batch QC checks track logP and partitioning to ensure it keeps performing predictably in live assays.

    Specification Experience

    Producing complex molecules means sticking to process constraints born from years of feedback. Here, our average customer keeps looking for high content, predictable purity, and strong shelf-life. Every lot leaves our facility after meeting minimum standards: residual solvent less than 0.5%, heavy metals below 10 ppm, ash content under 0.1%. These numbers come from both regulatory demand and practical user need—the difference between passing an HPLC/ultraviolet spec at a CRO or rerunning every plate twice due to inconsistent blank responses.

    Real-world use also highlights moisture sensitivity. During early work, we used less rigorous drying, leading to fluctuating performance in DMSO stock solutions. This problem traced back to bound water. We changed post-crystallization drying, now running long vacuum stages, and the number of user complaints about solubility issues dropped to nearly zero. This isn’t a trivial point. Pharmacokinetic experiments using high throughput screening can get completely thrown off if stock solutions degrade or don’t clarify properly.

    Flow through the value chain remains smooth when analytical data matches practical needs. We supply detailed NMR, IR, and elemental analysis—with S/N ratios and peak integrations—because synthetic chemists keep asking for raw files to trace every impurity and side product. When a researcher needs to map reverse-phase HPLC retention times for their method development, such transparency goes further than a simple certificate of analysis.

    Use Cases and Value in Drug Discovery

    Colleagues in academia and biotech sometimes press for cost-effective, repeated access to material, especially during multi-year grant projects. Our production model allows for kilo-scale runs, but we split down to smaller batch sizes on request. This reduces time in bureaucracy—deep-frozen bulk storage, periodic retesting—and keeps the product fresh.

    Regulatory requirements dominate pharmaceutical precursor markets. We adhere to cGMP guidelines for clinical intermediates. Even in pure research, failures in compliance hit everyone’s project cycles, so we tied our documentation and retention schedules directly into the audit chain. Cross-referenced batch records, chromatography, and chain-of-custody controls get checked by our own QA auditors before anything leaves the plant.

    The market doesn’t tolerate drops in reliability. This drives us to keep modernizing purification, drying, and even packaging. For this compound, light-excluding vials with pre-sealed PTFE liners cut back on trace oxidation or leaching from cap materials. Customers running long-term stability or stress tests need this form of attention to detail if their data are to make a difference downstream, either in publications or patent filings.

    Comparisons: What’s Different about This Compound

    Chemical manufacturers constantly face requests for “off the shelf” analogs, and there is a temptation to treat each as a modular compilation. What sets BzA-PAPA-PTS apart is its blend of functionalities: the guanidine with amidine, the rigidity from the benzimidazole, balanced by the substituted pyridyl and carboxamide. Most similar chemicals from the imidazole or phenylguanidine families lack either the rigid aromatic backbone or the solubilizing side chain, which cuts down on cell permeability or in vitro reactivity. When switching from our compound to related salts like the hydrochloride or free base, some customers encountered stability loss or variable crystallinity.

    Salt form selection matters far more than end-users sometimes realize. For instance, the para-toluene sulfonate delivers both enhanced solubility in polar organic solvents and longer shelf-life at room temperature, without the clumping or caking seen in phosphate or mesylate alternatives. We ran side-by-side dissolution studies comparing chloride, mesylate, and toluene sulfonate forms; the latter came through with more reproducible concentration curves and handled post-autoclave drying without color shift. In formulations where excipient compatibility counts, this means quicker transfer from pilot to scale-up.

    As a manufacturer, our R&D kept revisiting the impact of stoichiometry on crystalline behavior. For this benzimidazole derivative, even small changes in salt ratio influenced not just solubility, but also powder flow and compressibility—key considerations for anyone developing solid dosage forms or pre-formulation studies.

    Most raw suppliers provide their material without close control on salt-to-base reaction stoichiometry. We lock in a 1:1 molar ratio through in-process titration. This avoids over or undershooting during neutralization, delivering a product that resists simple moisture pick-up or fizzing in storage. It also sidesteps recurring complaints about “sticky powder” or unexpected byproduct in NMR.

    A frequent inquiry comes up about residual aromatic amines in benzimidazole preparation. We tackled this issue head-on: switched to cleaner residues in our precursor amines, ran standard UV/Vis absorbance benchmarks to spot side chain fluorophores, and used repeated washing and carbon filtration for crude intermediates. Even after synthesis, we retest for trace aniline- and toluidine-type fragments, ensuring biochemical users start from as clean a slate as possible.

    Supporting Chemical Development with Experience

    Outsiders sometimes underestimate the time spent optimizing seemingly “finished” molecules. Benzimidazole rings often act as a foundation for medicinal chemistry, but keep presenting surprises at scale. Each pressure in the synthesis chain—starting from nitration and reduction, through benzylation and amide coupling—offers a dozen points for minor impurities to sneak in, each visible to a diligent researcher at the chromatogram stage. We learned quickly that overlooked purification steps—polishing columns or clever phase separation—pay off just as much as shiny reactor controls.

    Bringing new personnel into our production environment, we stress traceability and analytical rigor. Rather than pushing for maximum throughput, we run pilot batches at smaller scale until both process and analysis line up. Every time a customer flagged a deviation, we changed SOPs or supplier standards if upstream materials fell short. The learning curve in chemical manufacturing always pushes from small pilot reactors towards scale-up, and it’s rare for the same protocol to work identically at ten times the volume. Each iteration usually uncovers a stumbled step: slow reagent addition rates, incomplete phase mixing, or solvents not as dry as assumed.

    Sharing these hurdles with our industrial partners and large research consortia, we find most challenges are universal: solvent efficiency, worker exposure, waste minimization, and post-synthesis purification. For this compound, it meant trialing greener alternatives for the amide coupling step, cutting back on DCM and DMF where possible, and pushing for lower-waste crystallization using ether or isopropanol as anti-solvents. Not every change sticks, but improvements accumulate. Fewer process incidents, less solvent disposal, less worker handling of caustic intermediates—these show up quietly as lower batch rejection rates and fewer support tickets from the field.

    Quality Assurance, Analytical Validation and Transparency

    A good chemical—especially a building block with multiple sensitive substituents—risks losing its cachet through inconsistent quality. Users in analytical and pharmacological research need material that holds up from the first gram to the tenth kilo. Our QC checks include high-resolution LC/MS to screen for isobaric and structural analogs, using both positive and negative ionization to reveal low-level contaminants. Diligent melting point and optical rotation checks help to confirm both enantiomeric composition and batch integrity, so end users never find surprises in NMR or MS analyses post-delivery.

    Any out-of-spec results lead straight back to our QA team, who review not just the analytical run, but preceding batch histories, solvent lots, and critical control points. Our chemists record every significant deviation and trend, making it possible to spot manufacturing drift before it impacts lot performance. We openly communicate these details with regular users, many of whom rely on our batch records to compile their own regulatory files for patent and IND submissions.

    With the rise of open science and reproducibility standards, more clients now ask for unabridged data—the full chromatograms, spectral integrations, and impurity lines. We have invested in data infrastructure to support secure sharing, keeping a ten-year archive by lot so researchers can audit precisely how every gram was produced and verified.

    Continuous Improvement and Problem-Solving Culture

    Making a benzimidazole salt over and over doesn’t get boring—it gets informative. Each run adds data: adjustments for raw material profiles, tweaks in drying protocols, new quenching or work-up steps. We have learned the value of parallel process testing, running multiple solvent systems or filtering strategies to handle new impurities flagged in customer feedback.

    No batch ever escapes minor variation, but we address recurring issues through weekly process review meetings. Sometimes a hint of discoloration signals minor decomposition, so we adjust storage temperature or packaging. Slow filtration or anti-solvent addition can point to new crystal morphology. As our customers bring projects to new stages—from assay development to scale-up—we provide the documentation and real-time support they need. Seeing our compounds end up in successful patent filings or clinical investigations gives more feedback than any internal review.

    The eventual goal for each product is long-term, science-driven relationship. We gain these by sharing process data, analytical traces, and supporting any new use cases. New applications and requests from the field keep our process development team on their toes, revisiting salt selection, solvent usage, and possible scale-up risks. As the landscape of drug discovery, chemical biology, and materials science evolves, so do our preparations, risk controls, and quality commitments.

    Conclusion: The Manufacturer’s Responsibility

    From experience, the toughest test for a chemical isn’t a compliance audit or spectacular yield. It’s the repeat call from customers, the request for larger or tweaked batches, the stories of successful downstream research. 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate entered our catalog because persistent scientific problems needed real answers. Reliable synthesis, rigorous analysis, and constant feedback from active users make this compound more than just a line in an inventory. Each lot gets personal attention, from substance procurement and process validation to every analytical trace, shaping what it means to be a supplier both now and as standards continue to rise.